Biosynex SA (EPA:ALBIO)
0.7980
+0.0040 (0.50%)
Apr 1, 2026, 1:02 PM CET
Biosynex Market Cap
Biosynex has a market cap or net worth of €14.89 million as of April 1, 2026. Its market cap has decreased by -47.83% in one year.
Market Cap
14.89M
Enterprise Value
67.17M
Revenue
97.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.80
Market Cap Chart
Since March 25, 2011, Biosynex's market cap has increased from 8.12M to 14.89M, an increase of 83.27%. That is a compound annual growth rate of 4.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 14.89M | 33.22% |
| Dec 31, 2025 | 11.17M | -39.63% |
| Dec 31, 2024 | 18.51M | -78.44% |
| Dec 29, 2023 | 85.85M | -39.13% |
| Dec 30, 2022 | 141.04M | -51.35% |
| Dec 31, 2021 | 289.89M | 91.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Carvolix | 187.21M |
| Median Technologies | 161.84M |
| Guerbet | 123.63M |
| Diagnostic Medical Systems | 34.70M |
| Novacyt | 28.26M |
| Implanet | 25.50M |
| Ikonisys | 22.97M |
| Theraclion | 21.05M |